1 month ago
OpenAI has fired three researchers for allegedly mishandling information, including work that involved an external organisation that ****** yses artificial intelligence (AI) models.
"Our investigation confirmed that these individuals mishandled sensitive information outside established company procedures, violating our policies and breaking the trust essential to our work," a spokesperson told the BBC.
The ChatGPT-maker did not name the sacked workers, but at least two of them were involved in safety research at the firm.
The firings come as the debate over AI safety and the risks the technology may pose to humanity has intensified in recent weeks.
"We have parted ways with three individuals for violating our policies on accessing and handling sensitive company information," OpenAI's spokesperson said.
#involved #individuals
"Our investigation confirmed that these individuals mishandled sensitive information outside established company procedures, violating our policies and breaking the trust essential to our work," a spokesperson told the BBC.
The ChatGPT-maker did not name the sacked workers, but at least two of them were involved in safety research at the firm.
The firings come as the debate over AI safety and the risks the technology may pose to humanity has intensified in recent weeks.
"We have parted ways with three individuals for violating our policies on accessing and handling sensitive company information," OpenAI's spokesperson said.
#involved #individuals
1 month ago
The Council on American-Islamic Relations (CAIR), antifa and the Muslim Brotherhood will be labeled domestic terrorist organizations under a new state law, after Florida leaders OK'd the designations at their Sept. 29 meeting.
These designations were in a 427-page packet submitted by the Florida Department of Law Enforcement for approval by Gov. Ron DeSantis and Florida Cabinet members: Attorney General James Uthmeier, Agriculture Commissioner Wilton Simpson and state Chief Financial Officer Blaise Ingoglia.
The packet also named numerous other groups labeled by the federal government as foreign terrorist organizations.
Although the Governor and Florida Cabinet approved these notices without any discussion, these designations don't come as a surprise. Weeks earlier, the governor and Cabinet approved an emergency rule setting procedures under a new state law (HB 1471) allowing them to designate terror groups.
Additionally, the day this law took effect, DeSantis announced his intentions to declare CAIR, the country's largest Muslim advocacy group, and antifa as domestic terror groups.
#Florida #muslim #governor
These designations were in a 427-page packet submitted by the Florida Department of Law Enforcement for approval by Gov. Ron DeSantis and Florida Cabinet members: Attorney General James Uthmeier, Agriculture Commissioner Wilton Simpson and state Chief Financial Officer Blaise Ingoglia.
The packet also named numerous other groups labeled by the federal government as foreign terrorist organizations.
Although the Governor and Florida Cabinet approved these notices without any discussion, these designations don't come as a surprise. Weeks earlier, the governor and Cabinet approved an emergency rule setting procedures under a new state law (HB 1471) allowing them to designate terror groups.
Additionally, the day this law took effect, DeSantis announced his intentions to declare CAIR, the country's largest Muslim advocacy group, and antifa as domestic terror groups.
#Florida #muslim #governor
2 months ago
SailPoint Inc. (NASDAQ:SAIL), a leading player within the enterprise identity security ****** e, recently expanded its strategic alliance with CrowdStrike. As part of the revised arrangement, the company's SailPoint SecOps Identity Intelligence will be integrated with CrowdStrike Falcon Next-Gen SIEM. This will help in expediting threat detection procedures, and will also incorporate access data and identity governance into the overall investigation process. The expanded partnership will facilitate security teams in lining up the identity insights with Falcon's existing security telemetry.
Copyright: franckito / 123RF Stock Photo
The announcement aligns strongly with SailPoint's broader strategic narrative revealed in its Q2 FY27 print. It builds upon several recent initiatives undertaken by the management, such as introduction of the SailPoint Identity Security solution. This is aimed toward integrating SailPoint Agentic Fabric with SailPoint Human Fabric for real-time discovery and security of complex digital ecosystems. The company also launched its Cursor Enterprise connector, which helps organizations to leverage a highly-integrated control plane to manage human developers and autonomous AI agents.
The recently released financials also back this narrative as the company delivered a 25% year-over-year growth in its annual recurring revenue, which stood at $1.231 billion. SailPoint generated $45 million in operating cash flow during the second quarter, along with $37 million in free cash flow.
By weaving SailPoint's identity intelligence into Falcon Next-Gen SIEM, customers gain extra context inside workflows they already rely on, making it easier to probe identity-related risks. The integration augments SailPoint's position at a time when identity threats are on a rise. This leads to an opportunity for SailPoint to cement itself as a leading provider of advanced security solutions.
#sailpoint #falcon #next
Copyright: franckito / 123RF Stock Photo
The announcement aligns strongly with SailPoint's broader strategic narrative revealed in its Q2 FY27 print. It builds upon several recent initiatives undertaken by the management, such as introduction of the SailPoint Identity Security solution. This is aimed toward integrating SailPoint Agentic Fabric with SailPoint Human Fabric for real-time discovery and security of complex digital ecosystems. The company also launched its Cursor Enterprise connector, which helps organizations to leverage a highly-integrated control plane to manage human developers and autonomous AI agents.
The recently released financials also back this narrative as the company delivered a 25% year-over-year growth in its annual recurring revenue, which stood at $1.231 billion. SailPoint generated $45 million in operating cash flow during the second quarter, along with $37 million in free cash flow.
By weaving SailPoint's identity intelligence into Falcon Next-Gen SIEM, customers gain extra context inside workflows they already rely on, making it easier to probe identity-related risks. The integration augments SailPoint's position at a time when identity threats are on a rise. This leads to an opportunity for SailPoint to cement itself as a leading provider of advanced security solutions.
#sailpoint #falcon #next
2 months ago
Intuitive Surgical (ISRG), maker of the da Vinci surgical robots, trades at about $382, some 36% below its 52-week high. Even so, you pay about 35.9 times trailing adjusted earnings. That is normalized net income with stock-based compensation added back, a basis meant to sit closer to the one ****** ysts forecast on, though the two are not defined identically. ****** ysts' forecasts run to 2027, the year Intuitive plans to start lowering what customers pay per use on some instruments.
The shares were trading about 11% lower the day after second-quarter results in July showed slower US procedure growth. US da Vinci procedures grew 12% in the second quarter, against 14% in the first. Management pointed to two likely causes, with the CFO noting that some customers say coverage changes are delaying deferrable procedures, alongside a little of the law of large numbers.
What the price still pays for is revenue growing faster than procedures. On the first-quarter call, the CFO credited that largely to da Vinci 5 and its higher pricing. More than half of the da Vinci systems Intuitive placed in the second quarter were da Vinci 5.
On ****** ysts' 2026 estimates, today's price is about 35.1 times earnings. On their 2027 estimates, it is about 31.4 times. The revenue forecast behind that looks modest: about 13.1% growth a year through 2027, against 20.7% growth over the past twelve months.
Consensus has earnings and revenue growing at a similar pace between 2026 and 2027, so margins hold roughly steady. Intuitive enters that stretch with an operating margin of 31.3% over the past twelve months, above its three-year average of 27.7%.
#intuitive #analysts #year #procedures
The shares were trading about 11% lower the day after second-quarter results in July showed slower US procedure growth. US da Vinci procedures grew 12% in the second quarter, against 14% in the first. Management pointed to two likely causes, with the CFO noting that some customers say coverage changes are delaying deferrable procedures, alongside a little of the law of large numbers.
What the price still pays for is revenue growing faster than procedures. On the first-quarter call, the CFO credited that largely to da Vinci 5 and its higher pricing. More than half of the da Vinci systems Intuitive placed in the second quarter were da Vinci 5.
On ****** ysts' 2026 estimates, today's price is about 35.1 times earnings. On their 2027 estimates, it is about 31.4 times. The revenue forecast behind that looks modest: about 13.1% growth a year through 2027, against 20.7% growth over the past twelve months.
Consensus has earnings and revenue growing at a similar pace between 2026 and 2027, so margins hold roughly steady. Intuitive enters that stretch with an operating margin of 31.3% over the past twelve months, above its three-year average of 27.7%.
#intuitive #analysts #year #procedures
2 months ago
An **** ysis of recent filings from American politicians shows that Accenture (NYSE: ACN) and Boston Scientific (NYSE: BSX) saw an uptick in purchases from notable politicians. Rep. Gilbert Ray Cisneros, Jr. (D-CA) bought Boston Scientific shares, according to a filing earlier this month. The trade was made on August 18, 2026. Rep. Ro Khanna (D-CA) also bought the stock twice, on August 3 and August 10, 2026, according to a filing filed on September 4, 2026. Neither politician sold Boston Scientific shares in the same period. Cisneros and Khanna were also the two buyers of Accenture shares in July and August.
This is based on data from Quiver Quantitative, a platform that tracks congressional stock trades from politicians.
Let's focus on BSX in this article.
BSX is down about 50% so far this year amid a cyberattack that disrupted manufacturing, order processing and shipments, forcing the company to withdraw its previous third-quarter and full-year outlook. Bulls say the market has priced in too severe an outcome. By Sept. 8, the company said its major distribution centers were shipping at or above normal levels, sterilization facilities were operating, and manufacturing had restarted at most plants. Bulls believe much of the disrupted revenue could be delayed rather than permanently lost as hospitals wait for products, reschedule procedures and the company works through its backlog.
Bulls also point to a business that was still growing. Second-quarter revenue rose 7.5% year over year and organic growth was 7%. Several core franchises delivered double-digit organic growth, including Interventional Cardiology and Vascular Therapies, Interventional Oncology and Embolization, and Neuromodulation.
#august #NYSE
This is based on data from Quiver Quantitative, a platform that tracks congressional stock trades from politicians.
Let's focus on BSX in this article.
BSX is down about 50% so far this year amid a cyberattack that disrupted manufacturing, order processing and shipments, forcing the company to withdraw its previous third-quarter and full-year outlook. Bulls say the market has priced in too severe an outcome. By Sept. 8, the company said its major distribution centers were shipping at or above normal levels, sterilization facilities were operating, and manufacturing had restarted at most plants. Bulls believe much of the disrupted revenue could be delayed rather than permanently lost as hospitals wait for products, reschedule procedures and the company works through its backlog.
Bulls also point to a business that was still growing. Second-quarter revenue rose 7.5% year over year and organic growth was 7%. Several core franchises delivered double-digit organic growth, including Interventional Cardiology and Vascular Therapies, Interventional Oncology and Embolization, and Neuromodulation.
#august #NYSE
2 months ago
Two former Robinhood engineers were charged with fraud on Tuesday in a Hyperliquid insider trading case, accused of buying futures contracts before their employer announced new token listings.
Hefu Chai, 36, and Huaisong Xiang, 30, each face one count of violating the Commodity Exchange Act and one count of wire fraud. Prosecutors say the pair made more than $50,000 apiece.
"Robinhood takes market integrity seriously and has zero tolerance for insider trading. We have robust insider trading policies and procedures in place, including for new crypto listings. We immediately investigated and reported this matter to law enforcement and regulators, and will continue to cooperate with the investigations," a Robinhood spokesperson told BeInCrypto.
Follow us on X to get the latest news as it happens
Hyperliquid runs a decentralized exchange built around perpetual futures. These are leveraged bets on a token's price that never expire, so a trader can hold the position indefinitely.
#robinhood #exchange #tuesday
Hefu Chai, 36, and Huaisong Xiang, 30, each face one count of violating the Commodity Exchange Act and one count of wire fraud. Prosecutors say the pair made more than $50,000 apiece.
"Robinhood takes market integrity seriously and has zero tolerance for insider trading. We have robust insider trading policies and procedures in place, including for new crypto listings. We immediately investigated and reported this matter to law enforcement and regulators, and will continue to cooperate with the investigations," a Robinhood spokesperson told BeInCrypto.
Follow us on X to get the latest news as it happens
Hyperliquid runs a decentralized exchange built around perpetual futures. These are leveraged bets on a token's price that never expire, so a trader can hold the position indefinitely.
#robinhood #exchange #tuesday
2 months ago
Apollo Global Management, Inc. (NYSE:APO) is reportedly in talks to acquire Johnson & Johnson (NYSE:JNJ) DePuy Synthes orthopedics business in a transaction that could value the unit at close to $20 billion, according to Bloomberg, as reported by Reuters. J&J generated $9.3 billion of revenue from the orthopedics business in 2025, making the potential transaction material for both companies. The discussions could reach an agreement within weeks, although J&J is also considering a public-market spin-off. This is consistent with J&J's October 2025 decision to separate DePuy Synthes within an expected 18-to-24-month timeframe and shift its MedTech portfolio toward higher-growth, higher-margin businesses.
For Apollo Global Management, Inc. (NYSE:APO), the attraction is the opportunity to acquire a large, established medical-device franchise with substantial recurring demand from joint-replacement and surgical procedures. A roughly $20 billion valuation against $9.3 billion of 2025 revenue implies a price-to-sales multiple of about 2.2x, giving Apollo room to pursue operational improvements, portfolio rationalization, and margin expansion if the business is acquired at an attractive valuation.
DePuy Synthes also has meaningful scale and leading positions across major orthopedics categories, while J&J has recently invested in technologies that could strengthen the franchise, including an agreement covering Gemtrack tracking technology for robotic and navigation-assisted joint procedures and the acquisition of Expanding Innovations for expandable spine implants. Apollo is also entering the potential deal from a position of considerable financial scale: it had approximately $1.05 trillion of ***** ets under management as of June 30, 2026, with $198 billion in equity strategies and $849 billion in credit strategies. Its second-quarter results included $111 billion of gross capital deployment, demonstrating the capacity to execute large transactions.
For Johnson & Johnson (NYSE:JNJ), a sale could accelerate the portfolio transformation that management has already identified as a strategic priority while potentially delivering a sizeable upfront cash inflow. J&J explicitly said its planned orthopedics separation should increase the company's top-line growth and operating margins by allowing it to concentrate on Oncology, Immunology, Neuroscience, Cardiovascular, Surgery and Vision.
The company has also been restructuring orthopedics, with $307 million of restructuring expense in 2025, following $167 million in 2024 and $319 million in 2023, primarily tied to market and product exits. A sale could therefore remove a business that has required restructuring resources while allowing J&J to redeploy capital toward areas it views as higher growth and higher margin.
#billion #depuy
For Apollo Global Management, Inc. (NYSE:APO), the attraction is the opportunity to acquire a large, established medical-device franchise with substantial recurring demand from joint-replacement and surgical procedures. A roughly $20 billion valuation against $9.3 billion of 2025 revenue implies a price-to-sales multiple of about 2.2x, giving Apollo room to pursue operational improvements, portfolio rationalization, and margin expansion if the business is acquired at an attractive valuation.
DePuy Synthes also has meaningful scale and leading positions across major orthopedics categories, while J&J has recently invested in technologies that could strengthen the franchise, including an agreement covering Gemtrack tracking technology for robotic and navigation-assisted joint procedures and the acquisition of Expanding Innovations for expandable spine implants. Apollo is also entering the potential deal from a position of considerable financial scale: it had approximately $1.05 trillion of ***** ets under management as of June 30, 2026, with $198 billion in equity strategies and $849 billion in credit strategies. Its second-quarter results included $111 billion of gross capital deployment, demonstrating the capacity to execute large transactions.
For Johnson & Johnson (NYSE:JNJ), a sale could accelerate the portfolio transformation that management has already identified as a strategic priority while potentially delivering a sizeable upfront cash inflow. J&J explicitly said its planned orthopedics separation should increase the company's top-line growth and operating margins by allowing it to concentrate on Oncology, Immunology, Neuroscience, Cardiovascular, Surgery and Vision.
The company has also been restructuring orthopedics, with $307 million of restructuring expense in 2025, following $167 million in 2024 and $319 million in 2023, primarily tied to market and product exits. A sale could therefore remove a business that has required restructuring resources while allowing J&J to redeploy capital toward areas it views as higher growth and higher margin.
#billion #depuy
2 months ago
Apollo Global Management, Inc. (NYSE:APO) is reportedly in talks to acquire Johnson & Johnson (NYSE:JNJ) DePuy Synthes orthopedics business in a transaction that could value the unit at close to $20 billion, according to Bloomberg, as reported by Reuters. J&J generated $9.3 billion of revenue from the orthopedics business in 2025, making the potential transaction material for both companies. The discussions could reach an agreement within weeks, although J&J is also considering a public-market spin-off. This is consistent with J&J's October 2025 decision to separate DePuy Synthes within an expected 18-to-24-month timeframe and shift its MedTech portfolio toward higher-growth, higher-margin businesses.
For Apollo Global Management, Inc. (NYSE:APO), the attraction is the opportunity to acquire a large, established medical-device franchise with substantial recurring demand from joint-replacement and surgical procedures. A roughly $20 billion valuation against $9.3 billion of 2025 revenue implies a price-to-sales multiple of about 2.2x, giving Apollo room to pursue operational improvements, portfolio rationalization, and margin expansion if the business is acquired at an attractive valuation.
DePuy Synthes also has meaningful scale and leading positions across major orthopedics categories, while J&J has recently invested in technologies that could strengthen the franchise, including an agreement covering Gemtrack tracking technology for robotic and navigation-assisted joint procedures and the acquisition of Expanding Innovations for expandable spine implants. Apollo is also entering the potential deal from a position of considerable financial scale: it had approximately $1.05 trillion of **** ets under management as of June 30, 2026, with $198 billion in equity strategies and $849 billion in credit strategies. Its second-quarter results included $111 billion of gross capital deployment, demonstrating the capacity to execute large transactions.
For Johnson & Johnson (NYSE:JNJ), a sale could accelerate the portfolio transformation that management has already identified as a strategic priority while potentially delivering a sizeable upfront cash inflow. J&J explicitly said its planned orthopedics separation should increase the company's top-line growth and operating margins by allowing it to concentrate on Oncology, Immunology, Neuroscience, Cardiovascular, Surgery and Vision.
The company has also been restructuring orthopedics, with $307 million of restructuring expense in 2025, following $167 million in 2024 and $319 million in 2023, primarily tied to market and product exits. A sale could therefore remove a business that has required restructuring resources while allowing J&J to redeploy capital toward areas it views as higher growth and higher margin.
#NYSE #johnson
For Apollo Global Management, Inc. (NYSE:APO), the attraction is the opportunity to acquire a large, established medical-device franchise with substantial recurring demand from joint-replacement and surgical procedures. A roughly $20 billion valuation against $9.3 billion of 2025 revenue implies a price-to-sales multiple of about 2.2x, giving Apollo room to pursue operational improvements, portfolio rationalization, and margin expansion if the business is acquired at an attractive valuation.
DePuy Synthes also has meaningful scale and leading positions across major orthopedics categories, while J&J has recently invested in technologies that could strengthen the franchise, including an agreement covering Gemtrack tracking technology for robotic and navigation-assisted joint procedures and the acquisition of Expanding Innovations for expandable spine implants. Apollo is also entering the potential deal from a position of considerable financial scale: it had approximately $1.05 trillion of **** ets under management as of June 30, 2026, with $198 billion in equity strategies and $849 billion in credit strategies. Its second-quarter results included $111 billion of gross capital deployment, demonstrating the capacity to execute large transactions.
For Johnson & Johnson (NYSE:JNJ), a sale could accelerate the portfolio transformation that management has already identified as a strategic priority while potentially delivering a sizeable upfront cash inflow. J&J explicitly said its planned orthopedics separation should increase the company's top-line growth and operating margins by allowing it to concentrate on Oncology, Immunology, Neuroscience, Cardiovascular, Surgery and Vision.
The company has also been restructuring orthopedics, with $307 million of restructuring expense in 2025, following $167 million in 2024 and $319 million in 2023, primarily tied to market and product exits. A sale could therefore remove a business that has required restructuring resources while allowing J&J to redeploy capital toward areas it views as higher growth and higher margin.
#NYSE #johnson
2 months ago
An ******* ysis of recent filings from American politicians shows that Accenture (NYSE: ACN) and Boston Scientific (NYSE: BSX) saw an uptick in purchases from notable politicians. Rep. Gilbert Ray Cisneros, Jr. (D-CA) bought Boston Scientific shares, according to a filing earlier this month. The trade was made on August 18, 2026. Rep. Ro Khanna (D-CA) also bought the stock twice, on August 3 and August 10, 2026, according to a filing filed on September 4, 2026. Neither politician sold Boston Scientific shares in the same period. Cisneros and Khanna were also the two buyers of Accenture shares in July and August.
This is based on data from Quiver Quantitative, a platform that tracks congressional stock trades from politicians.
Let's focus on BSX in this article.
BSX is down about 50% so far this year amid a cyberattack that disrupted manufacturing, order processing and shipments, forcing the company to withdraw its previous third-quarter and full-year outlook. Bulls say the market has priced in too severe an outcome. By Sept. 8, the company said its major distribution centers were shipping at or above normal levels, sterilization facilities were operating, and manufacturing had restarted at most plants. Bulls believe much of the disrupted revenue could be delayed rather than permanently lost as hospitals wait for products, reschedule procedures and the company works through its backlog.
Bulls also point to a business that was still growing. Second-quarter revenue rose 7.5% year over year and organic growth was 7%. Several core franchises delivered double-digit organic growth, including Interventional Cardiology and Vascular Therapies, Interventional Oncology and Embolization, and Neuromodulation.
#accenture
This is based on data from Quiver Quantitative, a platform that tracks congressional stock trades from politicians.
Let's focus on BSX in this article.
BSX is down about 50% so far this year amid a cyberattack that disrupted manufacturing, order processing and shipments, forcing the company to withdraw its previous third-quarter and full-year outlook. Bulls say the market has priced in too severe an outcome. By Sept. 8, the company said its major distribution centers were shipping at or above normal levels, sterilization facilities were operating, and manufacturing had restarted at most plants. Bulls believe much of the disrupted revenue could be delayed rather than permanently lost as hospitals wait for products, reschedule procedures and the company works through its backlog.
Bulls also point to a business that was still growing. Second-quarter revenue rose 7.5% year over year and organic growth was 7%. Several core franchises delivered double-digit organic growth, including Interventional Cardiology and Vascular Therapies, Interventional Oncology and Embolization, and Neuromodulation.
#accenture
2 months ago
Following an impressive second quarter FY27, Navan Inc. (NASDAQ:NAVN) announced its acquisition of BoomPop, an AI-powered meetings and events platform that has been recognized by Inc. as one of the fastest-growing private companies in America. Launched in 2023, BoomPop offers end-to-end event management solutions to enterprises, by leveraging artificial intelligence capabilities. Its offerings cover the entire spectrum of event management procedures including venue selection, vendor sourcing, contractual agreement, payments, and more. For Navan, this deal build on an existing alliance between the two entities, which was announced earlier in February. It marks the company's strategic push to expand its footprint across the meetings and events segment, where a large chunk of the spending is still done outside managed platforms.
LStockStudio/Shutterstock.com
The BoomPop acquisition follows a persistent enterprise market momentum reported by the company in its second quarter results, allowing Navan to enter into collaborative agreements with several leading companies during the quarter. These included Enbridge, Ingersoll Rand, ****** mins, and Evotec. Navan also concluded the deal to acquire Smartrips, a well-reputed travel management business, with the aim of bolstering its presence across a rapidly-growing Latin American market.
Notably, Navan registered adjusted net income of $14 million during the second quarter compared to an $8 million loss in Q2 FY26. It came at the back of year-over-year growth figures of 39% and 35% for subscription revenue and usage revenue, respectively.
Through full integration of BoomPop's staff and technology, Navan intends to expand its current meetings and events operations, accelerate its product development timeline, and satisfy growing customer interest. The company aims to deliver a more seamless experience covering travel, expense, meetings, and events.
#navan
LStockStudio/Shutterstock.com
The BoomPop acquisition follows a persistent enterprise market momentum reported by the company in its second quarter results, allowing Navan to enter into collaborative agreements with several leading companies during the quarter. These included Enbridge, Ingersoll Rand, ****** mins, and Evotec. Navan also concluded the deal to acquire Smartrips, a well-reputed travel management business, with the aim of bolstering its presence across a rapidly-growing Latin American market.
Notably, Navan registered adjusted net income of $14 million during the second quarter compared to an $8 million loss in Q2 FY26. It came at the back of year-over-year growth figures of 39% and 35% for subscription revenue and usage revenue, respectively.
Through full integration of BoomPop's staff and technology, Navan intends to expand its current meetings and events operations, accelerate its product development timeline, and satisfy growing customer interest. The company aims to deliver a more seamless experience covering travel, expense, meetings, and events.
#navan
2 months ago
Hyrox, the popular indoor fitness competition, is adjusting its policies and procedures after a world champion was allowed to continue at a competition in China last weekend despite suffering fecal incontinence.
Joanna Wietrzyk was competing in the age 16-24 elite event in Beijing on Saturday when she suddenly became ill. But despite fecal matter running down her legs, Wietrzyk was allowed to keep competing. The Australian continued on and ended up winning the race in a time of 1:01.23.
But in the days since, Hyrox has received heavy criticism for allowing Wietrzyk to continue competing despite the potential health risks. The company said that, despite having "clear biocontaminant and medical procedures in place," the situation "blurred" protocols and created "ambiguity in how they were applied and understood."
"I apologize to all that were directly or indirectly affected, as well as to everyone who felt like we did not handle the situation like we should have," Hyrox co-founder Moritz Furste said in a statement. "Hyrox made a mistake by not reacting immediately during the race. In the end, it is my job to foresee these potential incidents — and I did not.
"Of course, we started improving event processes, plus making rulebook changes immediately. As of this moment, there are new rules and procedures in place to prevent situations like this from happening again."
#allowed
Joanna Wietrzyk was competing in the age 16-24 elite event in Beijing on Saturday when she suddenly became ill. But despite fecal matter running down her legs, Wietrzyk was allowed to keep competing. The Australian continued on and ended up winning the race in a time of 1:01.23.
But in the days since, Hyrox has received heavy criticism for allowing Wietrzyk to continue competing despite the potential health risks. The company said that, despite having "clear biocontaminant and medical procedures in place," the situation "blurred" protocols and created "ambiguity in how they were applied and understood."
"I apologize to all that were directly or indirectly affected, as well as to everyone who felt like we did not handle the situation like we should have," Hyrox co-founder Moritz Furste said in a statement. "Hyrox made a mistake by not reacting immediately during the race. In the end, it is my job to foresee these potential incidents — and I did not.
"Of course, we started improving event processes, plus making rulebook changes immediately. As of this moment, there are new rules and procedures in place to prevent situations like this from happening again."
#allowed
2 months ago
Hyrox, the global endurance fitness race, is revising its protocols after a top athlete soiled herself and was allowed to continue during a competition in Beijing on Sept. 12.
Photos from the indoor competition show Australian Joanna Wietrzyk, the 22-year-old Hyrox world champion, with fecal matter running down her legs during the age 16-24 elite race. Wietzryk won the race with a time of 1:01:23, besting second-place finisher Alyssa McElheny of the United States by 45 seconds.
The incident sparked online outrage over potential health risks, prompting Hyrox co-founder Moritz Furste to release a statement on Monday, Sept. 14 admitting that race organizers failed by not removing Wietryzk from the competition.
"HYROX made a mistake by not reacting immediately during the race," Furste wrote in an Instagram post. "In the end it is my job to foresee these potential incidents – and I did not. Of course, we started improving event processes, plus making rulebook changes immediately. As of this moment, there are new rules and procedures in place to prevent situations like this from happening again."
USA TODAY Sports reached out to Hyrox, Wietrzyk and her coach for comment on Monday morning and did not immediately hear back.
#immediately
Photos from the indoor competition show Australian Joanna Wietrzyk, the 22-year-old Hyrox world champion, with fecal matter running down her legs during the age 16-24 elite race. Wietzryk won the race with a time of 1:01:23, besting second-place finisher Alyssa McElheny of the United States by 45 seconds.
The incident sparked online outrage over potential health risks, prompting Hyrox co-founder Moritz Furste to release a statement on Monday, Sept. 14 admitting that race organizers failed by not removing Wietryzk from the competition.
"HYROX made a mistake by not reacting immediately during the race," Furste wrote in an Instagram post. "In the end it is my job to foresee these potential incidents – and I did not. Of course, we started improving event processes, plus making rulebook changes immediately. As of this moment, there are new rules and procedures in place to prevent situations like this from happening again."
USA TODAY Sports reached out to Hyrox, Wietrzyk and her coach for comment on Monday morning and did not immediately hear back.
#immediately
2 months ago
Interested in Intuitive Surgical, Inc.? Here are five stocks we like better.
Global procedure growth remains intact despite a recent U.S. slowdown and Affordable Care Act-related uncertainty; Intuitive Surgical maintained its 13.5%–15.5% global procedure-growth outlook, expecting results near the midpoint.
Ambulatory surgery centers and international markets remain important expansion opportunities, with second-quarter system placements rising in the U.S. and abroad. However, China remains pressured by local competition and slower tenders, with improved visibility not expected until 2027.
Future growth could come from da Vinci 5 upgrades, Force Feedback instruments, new procedures and sites of care, and AI services such as Case Insights. The company also reported strong financial performance, including 21% revenue growth and operating and free-cash-flow margins above historical averages.
This AI ETF Is Missing the Biggest AI Winners
#affordable
Global procedure growth remains intact despite a recent U.S. slowdown and Affordable Care Act-related uncertainty; Intuitive Surgical maintained its 13.5%–15.5% global procedure-growth outlook, expecting results near the midpoint.
Ambulatory surgery centers and international markets remain important expansion opportunities, with second-quarter system placements rising in the U.S. and abroad. However, China remains pressured by local competition and slower tenders, with improved visibility not expected until 2027.
Future growth could come from da Vinci 5 upgrades, Force Feedback instruments, new procedures and sites of care, and AI services such as Case Insights. The company also reported strong financial performance, including 21% revenue growth and operating and free-cash-flow margins above historical averages.
This AI ETF Is Missing the Biggest AI Winners
#affordable
2 months ago
Anthony Knox will not appeal the decision by the NJSIAA controversies committee from last May to strip him of the 126-pound state wrestling championship he won in 2025, it was announced Friday by both the NJSIAA and Knox's attorneys.
The 2025 state **** le would have been the fourth of Knox's scholastic career at St. John Vianney High School. He is one of five wrestlers to win four state championships on the mat.
"In the matter of Anthony Knox v. NJSIAA, the **** ociation can confirm that all claims have been dismissed with prejudice. Mr. Knox, through his attorney, has agreed that he will not appeal the procedures, factual findings, or decision of the NJSIAA's Controversies Committee revoking his **** le. Accordingly, the NJSIAA's Committee's findings and decision stand,'' the NJSIAA said in a statement.
"The case is over. The case has been dismissed,'' Knox's attorney Patrick J. Jennings said.
Jennings declined to comment further.
#jennings #controversies
The 2025 state **** le would have been the fourth of Knox's scholastic career at St. John Vianney High School. He is one of five wrestlers to win four state championships on the mat.
"In the matter of Anthony Knox v. NJSIAA, the **** ociation can confirm that all claims have been dismissed with prejudice. Mr. Knox, through his attorney, has agreed that he will not appeal the procedures, factual findings, or decision of the NJSIAA's Controversies Committee revoking his **** le. Accordingly, the NJSIAA's Committee's findings and decision stand,'' the NJSIAA said in a statement.
"The case is over. The case has been dismissed,'' Knox's attorney Patrick J. Jennings said.
Jennings declined to comment further.
#jennings #controversies
2 months ago
Summer Lynn, an influencer from Alabama, went viral for sharing her cosmetic procedure journey on social media
She has undergone multiple surgeries, including a nose job, chin liposuction and a Brazilian ******* lift, among others
She says she shares her experiences to normalize cosmetic procedures and connect with others who feel similarly
An influencer in her 20s is giving up all the secrets behind her viral cosmetic procedures.
PEOPLE spoke exclusively with New Hope, Ala., resident Summer Lynn, who went viral in July for sharing an Instagram Reel of all her transformations with an overlay that read, "customizing my avatar because we only live 80 years."
#procedures
She has undergone multiple surgeries, including a nose job, chin liposuction and a Brazilian ******* lift, among others
She says she shares her experiences to normalize cosmetic procedures and connect with others who feel similarly
An influencer in her 20s is giving up all the secrets behind her viral cosmetic procedures.
PEOPLE spoke exclusively with New Hope, Ala., resident Summer Lynn, who went viral in July for sharing an Instagram Reel of all her transformations with an overlay that read, "customizing my avatar because we only live 80 years."
#procedures
2 months ago
Prince Harry and Meghan Markle are reportedly worried about daily school runs for their kids, Archie and Lilibet. Although the Sussexes returned to the UK on August 26, they have seemingly come back without securing taxpayer-funded security. It has understandably fueled concern for the anxious parents about their children's safety.
A close friend of Prince Harry and Meghan Markle has reportedly voiced concern about daily school runs for their kids on the couple's behalf. A friend dished to The Telegraph: "It is absolutely the biggest area of concern. It creates the most dangers." Although the Sussexes returned to the UK on August 26, they have seemingly come back without securing taxpayer-funded security. It has understandably fuelled concern for the anxious parents about their children's safety.
According to the outlet, Archie and Lilibet's school has already been notified of their attendance. Not only that, teachers are already mandated to follow specific instructions. Additionally, the school is required to follow certain rules and procedures for maintaining the children's protection.
Meanwhile, Harry and Meghan are reportedly awaiting a definite response regarding their taxpayer-funded security from the UK's Home Office. According to the outlet, the couple would like to know if they are eligible for police protection now that they are residing in Britain. Notably, the Sussexes were previously denied protection rights during visits to the UK.
Scott Hamer, a former Metropolitan Police royalty and specialist protection officer, showed his support for the Duke of Sussex. He told the outlet: "If there is a credible threat to him and his family, it should be objectively ****** sed. If there is a genuine risk, the state should provide protection. If not, that's fine, but let him know."
#protection #harry #meghan #concern
A close friend of Prince Harry and Meghan Markle has reportedly voiced concern about daily school runs for their kids on the couple's behalf. A friend dished to The Telegraph: "It is absolutely the biggest area of concern. It creates the most dangers." Although the Sussexes returned to the UK on August 26, they have seemingly come back without securing taxpayer-funded security. It has understandably fuelled concern for the anxious parents about their children's safety.
According to the outlet, Archie and Lilibet's school has already been notified of their attendance. Not only that, teachers are already mandated to follow specific instructions. Additionally, the school is required to follow certain rules and procedures for maintaining the children's protection.
Meanwhile, Harry and Meghan are reportedly awaiting a definite response regarding their taxpayer-funded security from the UK's Home Office. According to the outlet, the couple would like to know if they are eligible for police protection now that they are residing in Britain. Notably, the Sussexes were previously denied protection rights during visits to the UK.
Scott Hamer, a former Metropolitan Police royalty and specialist protection officer, showed his support for the Duke of Sussex. He told the outlet: "If there is a credible threat to him and his family, it should be objectively ****** sed. If there is a genuine risk, the state should provide protection. If not, that's fine, but let him know."
#protection #harry #meghan #concern
2 months ago
By Mary Guzman
Apple's July 10, 2026 lawsuit against OpenAI, filed in the Northern District of California just five weeks after OpenAI's confidential Form S‑1 targeted a trillion‑dollar valuation, presents a governance case study with implications far beyond Silicon Valley. In Apple Inc. v. Liu, No. 5:26‑cv‑07078, Apple alleges that OpenAI Group PBC, OpenAI Foundation, io Products LLC, former Apple vice president Tang Yew Tan, and former Apple engineer Chang Liu engaged in a coordinated effort to obtain confidential Apple hardware designs, supply‑chain intelligence, and unreleased product specifications. Apple claims the misappropriation reached every level of OpenAI's hardware organization and seeks preliminary and permanent injunctions, compensatory damages, a reasonable royalty in the alternative, exemplary damages for willful misappropriation, and attorneys' fees*. OpenAI denies all allegations and points to Apple's allegedly lax exit procedures as the key negating factor.
From a governance perspective, the case highlights a recurring pattern: trade‑secret disputes that appear straightforward to the public often reveal deeper structural weaknesses inside the victim organization. The industry has seen versions of this before—emails encouraging departing employees to "bring what you know," or the more extreme mole scenario, as in Deel v. Rippling. These are not just operational failures; they are governance failures that should alarm any board member or investor expecting a clean exit or a stable competitive position.
The risk is accelerating. More than 1,500 federal trade‑secret cases were filed in 2025 – the highest ever – and still only a fraction of the true number. AI proliferation, high employee mobility, and limits on non‑competes ensure that trade‑secret litigation will continue to rise. Meanwhile, companies increasingly rely on trade‑secret protection (surpassing the long-favored patent-or-die approach) recognizing that patents disclose the playbook to competitors and nation‑state adversaries. In a world where competitive advantage is often driven by a process rather than the output it creates, trade secrets are often the most valuable and strategic IP ******* et.
But the governance question is always the same: Did the company actually have protectable trade secrets? That requires: a) legal ownership of the innovation, b) demonstrable uniqueness that creates value, and c) "reasonable measures" to protect it.
#confidential #case
Apple's July 10, 2026 lawsuit against OpenAI, filed in the Northern District of California just five weeks after OpenAI's confidential Form S‑1 targeted a trillion‑dollar valuation, presents a governance case study with implications far beyond Silicon Valley. In Apple Inc. v. Liu, No. 5:26‑cv‑07078, Apple alleges that OpenAI Group PBC, OpenAI Foundation, io Products LLC, former Apple vice president Tang Yew Tan, and former Apple engineer Chang Liu engaged in a coordinated effort to obtain confidential Apple hardware designs, supply‑chain intelligence, and unreleased product specifications. Apple claims the misappropriation reached every level of OpenAI's hardware organization and seeks preliminary and permanent injunctions, compensatory damages, a reasonable royalty in the alternative, exemplary damages for willful misappropriation, and attorneys' fees*. OpenAI denies all allegations and points to Apple's allegedly lax exit procedures as the key negating factor.
From a governance perspective, the case highlights a recurring pattern: trade‑secret disputes that appear straightforward to the public often reveal deeper structural weaknesses inside the victim organization. The industry has seen versions of this before—emails encouraging departing employees to "bring what you know," or the more extreme mole scenario, as in Deel v. Rippling. These are not just operational failures; they are governance failures that should alarm any board member or investor expecting a clean exit or a stable competitive position.
The risk is accelerating. More than 1,500 federal trade‑secret cases were filed in 2025 – the highest ever – and still only a fraction of the true number. AI proliferation, high employee mobility, and limits on non‑competes ensure that trade‑secret litigation will continue to rise. Meanwhile, companies increasingly rely on trade‑secret protection (surpassing the long-favored patent-or-die approach) recognizing that patents disclose the playbook to competitors and nation‑state adversaries. In a world where competitive advantage is often driven by a process rather than the output it creates, trade secrets are often the most valuable and strategic IP ******* et.
But the governance question is always the same: Did the company actually have protectable trade secrets? That requires: a) legal ownership of the innovation, b) demonstrable uniqueness that creates value, and c) "reasonable measures" to protect it.
#confidential #case
2 months ago
Sunnyvale, California-based Intuitive Surgical, Inc. (ISRG) develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care. Valued at $133.1 billion by market cap, the company offers endoscopes, endoscopic retractors and disectors, scissors, scalpels, forceps, needle holders, electrocautery, ultrasonic cutters, and accessories during surgical procedures.
Companies worth $10 billion or more are generally described as "large-cap stocks," and ISRG definitely fits that description, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the medical instruments & supplies industry. Intuitive Surgical excels in robotic-assisted surgery with its gold-standard da Vinci system, backed by strong brand reputation, continuous R&D investment, and comprehensive surgeon training, driving user proficiency and patient outcomes.
Dear Sandisk Stock Fans, Mark Your Calendars for August 31
Bill Gates Says 'We Need Time to Prepare' for an Economic Upheaval — Especially the $20-an-Hour Workers Being Replaced by $10-an-Hour Robots
Dear Palantir Stock Fans, Here's What Maven's Billion-Dollar ARR Means for PLTR
#intuitive #dear
Companies worth $10 billion or more are generally described as "large-cap stocks," and ISRG definitely fits that description, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the medical instruments & supplies industry. Intuitive Surgical excels in robotic-assisted surgery with its gold-standard da Vinci system, backed by strong brand reputation, continuous R&D investment, and comprehensive surgeon training, driving user proficiency and patient outcomes.
Dear Sandisk Stock Fans, Mark Your Calendars for August 31
Bill Gates Says 'We Need Time to Prepare' for an Economic Upheaval — Especially the $20-an-Hour Workers Being Replaced by $10-an-Hour Robots
Dear Palantir Stock Fans, Here's What Maven's Billion-Dollar ARR Means for PLTR
#intuitive #dear
2 months ago
Kentucky Football fans have essentially become lawyers through Twitter law school over the last few weeks, with Mark Mitchell's ups and downs changing every day, and ultimately, Kentucky got burned by that situation, with Mitchell back at Missouri.
In Wednesday's news, Kentucky fans can get excited about a new court ruling, with Louisville Circuit Judge Brian Edwards ruling in favor of Alex Afari, which gives Afari the eligibility to play one more season at Kentucky.
Afari will now be given a temporary restraining order and will be able to lace up his shoes and play in a Kentucky Wildcat jersey again.
However, not long after this news broke, head coach Will Stein hopped on the SEC coaches' teleconference and said Kentucky still needs to get through some procedures before Afari can play in live games.
"He's been working with us throughout fall camp, so we're waiting for a few more things to be answered," said Stein. "And if those get answered, then we'll proceed."
#mark
In Wednesday's news, Kentucky fans can get excited about a new court ruling, with Louisville Circuit Judge Brian Edwards ruling in favor of Alex Afari, which gives Afari the eligibility to play one more season at Kentucky.
Afari will now be given a temporary restraining order and will be able to lace up his shoes and play in a Kentucky Wildcat jersey again.
However, not long after this news broke, head coach Will Stein hopped on the SEC coaches' teleconference and said Kentucky still needs to get through some procedures before Afari can play in live games.
"He's been working with us throughout fall camp, so we're waiting for a few more things to be answered," said Stein. "And if those get answered, then we'll proceed."
#mark
2 months ago
United Parcel Service announced Monday afternoon the adoption of a new operating model and leadership structure aimed at better exploiting its global network to accelerate profit growth as it evolves from a traditional small package carrier to more of an integrated logistics provider.
The timing of the move coincides with the major phase-out of low-margin Amazon business and downsizing of its domestic parcel network, which were largely completed by the end of June.
Under the new approach, UPS (NYSE: UPS) will standardize processes and procedures across geographies while maintaining the flexibility to meet the unique needs of local markets. UPS said it wanted to give customers greater consistency, agility, and scale as the company deemphasizes its traditional status as a small package carrier to focus more on being an integrated logistics provider.
As e-commerce growth normalized following the Covid-fueled boom and low-cost delivery competitors entered the market, UPS parcel volumes have stagnated.
Why It Matters: The company has stressed for two years that it intends to deemphasize last-mile delivery of e-commerce packages and focus more on high-value, premium market segments like healthcare, industrial, and automotive logistics, as well as services for small-and-medium size businesses. Now there is more concrete evidence about the direction UPS is going.
#Growth #package #integrated #provider
The timing of the move coincides with the major phase-out of low-margin Amazon business and downsizing of its domestic parcel network, which were largely completed by the end of June.
Under the new approach, UPS (NYSE: UPS) will standardize processes and procedures across geographies while maintaining the flexibility to meet the unique needs of local markets. UPS said it wanted to give customers greater consistency, agility, and scale as the company deemphasizes its traditional status as a small package carrier to focus more on being an integrated logistics provider.
As e-commerce growth normalized following the Covid-fueled boom and low-cost delivery competitors entered the market, UPS parcel volumes have stagnated.
Why It Matters: The company has stressed for two years that it intends to deemphasize last-mile delivery of e-commerce packages and focus more on high-value, premium market segments like healthcare, industrial, and automotive logistics, as well as services for small-and-medium size businesses. Now there is more concrete evidence about the direction UPS is going.
#Growth #package #integrated #provider
2 months ago
Sept 1 (Reuters) - UnitedHealth's insurance unit said on Tuesday that a broad range of conditions will no longer need prior approval, effective October 1, as it aims to eliminate prior authorization for 30% of healthcare services by the end of this year.
Here are the details:
• The reduction spans a broad mix of services across multiple clinical specialties, including cardiology, genetic and laboratory testing, chiropractic care, physical, occupational and speech therapy, orthopedic and musculoskeletal procedures, among others.
• The prior authorization requirements are being eliminated across its commercial plans, Medicare Advantage for older adults and individual insurance under the Affordable Care Act, also known as Obamacare, and some other types of plans.
• Health insurers have been taking measures to simplify their requirements for prior authorization on medicines and medical services after complaints from patients and doctors over excessive paperwork that can delay or even deny needed care.
#prior
Here are the details:
• The reduction spans a broad mix of services across multiple clinical specialties, including cardiology, genetic and laboratory testing, chiropractic care, physical, occupational and speech therapy, orthopedic and musculoskeletal procedures, among others.
• The prior authorization requirements are being eliminated across its commercial plans, Medicare Advantage for older adults and individual insurance under the Affordable Care Act, also known as Obamacare, and some other types of plans.
• Health insurers have been taking measures to simplify their requirements for prior authorization on medicines and medical services after complaints from patients and doctors over excessive paperwork that can delay or even deny needed care.
#prior
2 months ago
America is debating data centers as though technological leadership and affordable electricity are competing goals. That framing misses the opportunity. Hyperscale campuses should enter the grid as integrated energy projects that add generation, storage, flexibility, and resilience, not merely as large loads.An April 2026 Pew Research Center **** ysis found more than 3,000 operating U.S. data centers and more than 1,500 in development, with 67% of planned facilities in rural communities. Lawrence Berkeley National Laboratory projects data centers could consume 11.8% of U.S. electricity by 2030. Goldman Sachs projects demand could rise from 31 GW in 2025 to 66 GW in 2027.
COMMENTARY
Those figures demand a legal and regulatory model that rewards projects capable of solving the problems they create. Hyperscale facilities seeking expedited approval should bring enough new supply and flexibility to serve contracted demand, pay the infrastructure costs they cause, and provide enforceable grid support during emergencies.A 2025 executive order accelerated permitting for qualifying artificial intelligence (AI) data centers and supporting power infrastructure. The White House's 2026 Ratepayer Protection Pledge called on hyperscalers to bring new generation, pay grid costs, and protect existing customers.In October 2025, the Energy Secretary used Section 403 of the Department of Energy Organization Act to ask the Federal Energy Regulatory Commission (FERC) to consider reforms for loads generally exceeding 20 MW in Docket No. RM26-4-000. FERC declined to impose one national process, instead opening separate Federal Power Act Section 206 proceedings in June 2026 for all six regional transmission organizations (RTOs) and independent system operators (ISOs), Docket Nos. EL26-67-000 through EL26-72-000.The orders question whether existing tariffs are just and reasonable, and identify five reform areas: study procedures, cost-shifting protections, co-location and behind-the-meter generation, flexible transmission service, and generation serving nearby loads.
[evtx_block slug="ep-dpx-26-textblock"]
Texas has responded by requiring large-load customers to shoulder infrastructure costs and by developing curtailment and co-location rules under Senate Bill 6. New York has paused certain hyperscale permits while it develops ratepayer, grid, water, and community protections. Both approaches point toward the same durable result: a power-positive approval pathway that converts legitimate public concerns into measurable design and operating obligations.Other states are building tariffs around that principle. Wisconsin extended its very-large-customer tariff to a 15-year minimum, lowered eligibility to 100 MW, and strengthened cost-shift protections. Long commitments, minimum-demand payments, security requirements, and exit charges are now central project economics.That makes the interconnection agreement co-equal with the engineering, procurement, and construction cont
COMMENTARY
Those figures demand a legal and regulatory model that rewards projects capable of solving the problems they create. Hyperscale facilities seeking expedited approval should bring enough new supply and flexibility to serve contracted demand, pay the infrastructure costs they cause, and provide enforceable grid support during emergencies.A 2025 executive order accelerated permitting for qualifying artificial intelligence (AI) data centers and supporting power infrastructure. The White House's 2026 Ratepayer Protection Pledge called on hyperscalers to bring new generation, pay grid costs, and protect existing customers.In October 2025, the Energy Secretary used Section 403 of the Department of Energy Organization Act to ask the Federal Energy Regulatory Commission (FERC) to consider reforms for loads generally exceeding 20 MW in Docket No. RM26-4-000. FERC declined to impose one national process, instead opening separate Federal Power Act Section 206 proceedings in June 2026 for all six regional transmission organizations (RTOs) and independent system operators (ISOs), Docket Nos. EL26-67-000 through EL26-72-000.The orders question whether existing tariffs are just and reasonable, and identify five reform areas: study procedures, cost-shifting protections, co-location and behind-the-meter generation, flexible transmission service, and generation serving nearby loads.
[evtx_block slug="ep-dpx-26-textblock"]
Texas has responded by requiring large-load customers to shoulder infrastructure costs and by developing curtailment and co-location rules under Senate Bill 6. New York has paused certain hyperscale permits while it develops ratepayer, grid, water, and community protections. Both approaches point toward the same durable result: a power-positive approval pathway that converts legitimate public concerns into measurable design and operating obligations.Other states are building tariffs around that principle. Wisconsin extended its very-large-customer tariff to a 15-year minimum, lowered eligibility to 100 MW, and strengthened cost-shift protections. Long commitments, minimum-demand payments, security requirements, and exit charges are now central project economics.That makes the interconnection agreement co-equal with the engineering, procurement, and construction cont
2 months ago
Two years ago, CrowdStrike Holdings, Inc. (CRWD) was the company blamed for a global technology failure, after a faulty software update halted flights and postponed hospital procedures worldwide, according to CNBC.
On Wednesday, the same company delivered what its own chief executive called the best quarter in its history. The distance between those two moments says more about where cybersecurity spending is headed than any single earnings report could.
CrowdStrike's fiscal second quarter revenue reached $1.47 billion, up 26% from a year earlier, and adjusted earnings came in at 31 cents a share, beating Wall Street's estimate of 29 cents, CNBC reported.
The company also added a record $332.8 million in new annual recurring revenue, a 51% jump from last year, according to a CrowdStrike press release.
Shares jumped as much as 12% in after hours trading Wednesday, then closed up 20.5% during Thursday's session.
#cnbc
On Wednesday, the same company delivered what its own chief executive called the best quarter in its history. The distance between those two moments says more about where cybersecurity spending is headed than any single earnings report could.
CrowdStrike's fiscal second quarter revenue reached $1.47 billion, up 26% from a year earlier, and adjusted earnings came in at 31 cents a share, beating Wall Street's estimate of 29 cents, CNBC reported.
The company also added a record $332.8 million in new annual recurring revenue, a 51% jump from last year, according to a CrowdStrike press release.
Shares jumped as much as 12% in after hours trading Wednesday, then closed up 20.5% during Thursday's session.
#cnbc
2 months ago
Rezolve Ai (NASDAQ:RZLV) has announced that Google (NASDAQ:GOOG) selected its proprietary distributed database technology for use within Google Cloud infrastructure, marking what Rezolve describes as the platform's first major commercial deployment with a large technology company.
According to Rezolve Ai, the technology is supporting Google Cloud Web3 blockchain datasets, providing infrastructure for data indexing and processing pipelines across multiple blockchain networks.
The first phase encompasses complete historical information from 10 blockchain networks, representing approximately 100 terabytes of data.
Rezolve said its technology applies a series of verification procedures before information reaches Google Cloud's public datasets. Each blockchain block is subjected to six cryptographic checks, alongside schema validation, structural verification and cross-validation.
The deployment provides Rezolve with a significant commercial test of technology that the company has been developing as part of its broader enterprise infrastructure strategy.
#Google #NASDAQ #first #deployment
According to Rezolve Ai, the technology is supporting Google Cloud Web3 blockchain datasets, providing infrastructure for data indexing and processing pipelines across multiple blockchain networks.
The first phase encompasses complete historical information from 10 blockchain networks, representing approximately 100 terabytes of data.
Rezolve said its technology applies a series of verification procedures before information reaches Google Cloud's public datasets. Each blockchain block is subjected to six cryptographic checks, alongside schema validation, structural verification and cross-validation.
The deployment provides Rezolve with a significant commercial test of technology that the company has been developing as part of its broader enterprise infrastructure strategy.
#Google #NASDAQ #first #deployment
2 months ago
Busy Philipps is sharing new details about a terrifying health scare that led to the "weirdest six months" of her life.
The actress recently revealed that she underwent two surgeries earlier this year after doctors discovered a rare, slow-growing brain tumor. While she's now safely on the other side of the procedures and feels "grateful" to be alive, she admits she came very close to skipping the appointment that caught the mass.
More from SheKnows
Whitney Port Says This 'Annoying' Surgery Is the Next Step in Her IVF Journey
Philipps told People that she'd been curious about getting a full-body Prenuvo MRI scan after seeing it on Instagram, even though her primary care doctor said it wasn't necessary since she was young, healthy, and her annual labs were normal. Going with her gut instinct, Philipps booked the appointment anyway.
#port
The actress recently revealed that she underwent two surgeries earlier this year after doctors discovered a rare, slow-growing brain tumor. While she's now safely on the other side of the procedures and feels "grateful" to be alive, she admits she came very close to skipping the appointment that caught the mass.
More from SheKnows
Whitney Port Says This 'Annoying' Surgery Is the Next Step in Her IVF Journey
Philipps told People that she'd been curious about getting a full-body Prenuvo MRI scan after seeing it on Instagram, even though her primary care doctor said it wasn't necessary since she was young, healthy, and her annual labs were normal. Going with her gut instinct, Philipps booked the appointment anyway.
#port
2 months ago
The U.S. Postal Service unveiled new requirements for mail ballots less than two weeks before some states begin sending them and in time for the conservative majority of the Supreme Court to clear the way for President Donald Trump's executive order limiting the method to be used in November's elections.
The provisions are still subject to additional legal challenges and may not go into effect in time to meet the tight deadline to change procedures for the midterm elections. They would forbid the Postal Service from sending mail ballots from any state that does not comply with Trump's order and would require an overhaul of the envelopes containing the ballots.
Despite the high court's initial clearance of the order, it did not decide on the constitutionality of the new regulation— only on whether the challenge was premature when Democratic-controlled states persuaded a federal judge in Boston to suspend them in June. A second ruling from the same judge would prevent the Postal Service from implementing any procedural changes before this year's midterms and would likely need to be nullified, as well.
Time is running out for the administration to make any changes in the nation's voting procedures. The first mail ballots are required to be sent to military and overseas voters from North Carolina on Sept. 4. At that point, it would be virtually impossible for all states to alter the formatting of their mail ballots to comply with Trump's directive. The Postal Service rule also requires states to submit voter lists in order to get their mail ballots delivered.
The Postal Service said it could not comment on its rule given the litigation.
#elections #procedures
The provisions are still subject to additional legal challenges and may not go into effect in time to meet the tight deadline to change procedures for the midterm elections. They would forbid the Postal Service from sending mail ballots from any state that does not comply with Trump's order and would require an overhaul of the envelopes containing the ballots.
Despite the high court's initial clearance of the order, it did not decide on the constitutionality of the new regulation— only on whether the challenge was premature when Democratic-controlled states persuaded a federal judge in Boston to suspend them in June. A second ruling from the same judge would prevent the Postal Service from implementing any procedural changes before this year's midterms and would likely need to be nullified, as well.
Time is running out for the administration to make any changes in the nation's voting procedures. The first mail ballots are required to be sent to military and overseas voters from North Carolina on Sept. 4. At that point, it would be virtually impossible for all states to alter the formatting of their mail ballots to comply with Trump's directive. The Postal Service rule also requires states to submit voter lists in order to get their mail ballots delivered.
The Postal Service said it could not comment on its rule given the litigation.
#elections #procedures
2 months ago
Alvotech (NASDAQ:ALVO) extended its winning streak to a 5th consecutive day on Monday, jumping 18.51 percent to finish at $5.25 apiece, after the Bank of America (BofA) raised its price target for the company.
In its recent coverage, BofA initiated a buy recommendation on Alvotech shares with a price target of $7, amid the closure of the inspection of its manufacturing facility in Iceland, alongside progress in the commercialization of two of its drug candidates in the US and Asia.
The coverage followed the Food and Drug Administration's (FDA) voluntary closure of its inspection of Alvotech's (NASDAQ:ALVO) manufacturing facility in Reykjavik, Iceland, over several practices at its plant in Reykjavik, such as handling of complaints, subpar contamination prevention procedures, and poor quality and purity vetting, among others.
"This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing operations," CEO Lisa Graver said.
"With the conclusion of the FDA's recent inspection, we are confident that the actions we have taken have effectively addressed the observations identified. We continue to work with the FDA to advance our recent Biologics License Applications towards approval," she noted.
#recent #inspection #reykjavik #drug
In its recent coverage, BofA initiated a buy recommendation on Alvotech shares with a price target of $7, amid the closure of the inspection of its manufacturing facility in Iceland, alongside progress in the commercialization of two of its drug candidates in the US and Asia.
The coverage followed the Food and Drug Administration's (FDA) voluntary closure of its inspection of Alvotech's (NASDAQ:ALVO) manufacturing facility in Reykjavik, Iceland, over several practices at its plant in Reykjavik, such as handling of complaints, subpar contamination prevention procedures, and poor quality and purity vetting, among others.
"This is an important milestone for Alvotech and reflects the significant work our teams have undertaken to further strengthen our quality systems and manufacturing operations," CEO Lisa Graver said.
"With the conclusion of the FDA's recent inspection, we are confident that the actions we have taken have effectively addressed the observations identified. We continue to work with the FDA to advance our recent Biologics License Applications towards approval," she noted.
#recent #inspection #reykjavik #drug
2 months ago
Medtronic plc (NYSE:MDT) and Tenet Healthcare Corporation (NYSE:THC) offer investors two very different healthcare growth stories. Medtronic's (NYSE:MDT) thesis rests on whether a new generation of medical devices can produce a durable turnaround across its enormous portfolio. Tenet (NYSE:THC), meanwhile, is generating stronger earnings by improving hospital profitability and focusing its ambulatory business on higher-acuity procedures.
The comparison ultimately comes down to whether investors prefer Medtronic's (NYSE:MDT) innovation-led recovery or Tenet's (NYSE:THC) stronger operating leverage.
Medtronic (NYSE:MDT) reported its highest annual revenue growth in a decade in its fiscal Q4 and full-year 2026 results, suggesting that years of investment in faster-growing technologies are beginning to produce meaningful results. Growth opportunities including Affera, Symplicity, Hugo, Altaviva, and Stealth AXiS give the company several potential drivers rather than leaving its recovery dependent on a single product.
Cardiac Ablation Solutions has emerged as a particularly important contributor. Revenue increased 78% globally, including 124% growth in the United States, as newer products strengthened Medtronic's (NYSE:MDT) position in the expanding cardiac-ablation market. The company is also investing in innovation and acquisitions, including targeted investments in intracardiac echocardiography catheter technology.
The breadth of Medtronic's (NYSE:MDT) pipeline supports the possibility that its recent acceleration can spread across more of the portfolio. Improving sentiment toward the wider medical-technology sector could provide an additional catalyst if the company maintains its execution. BTIG has argued that MedTech may be stabilizing following a period of underperformance, although company-specific results will ultimately matter more than broader sector sentiment.
#results #medtronic #healthcare
The comparison ultimately comes down to whether investors prefer Medtronic's (NYSE:MDT) innovation-led recovery or Tenet's (NYSE:THC) stronger operating leverage.
Medtronic (NYSE:MDT) reported its highest annual revenue growth in a decade in its fiscal Q4 and full-year 2026 results, suggesting that years of investment in faster-growing technologies are beginning to produce meaningful results. Growth opportunities including Affera, Symplicity, Hugo, Altaviva, and Stealth AXiS give the company several potential drivers rather than leaving its recovery dependent on a single product.
Cardiac Ablation Solutions has emerged as a particularly important contributor. Revenue increased 78% globally, including 124% growth in the United States, as newer products strengthened Medtronic's (NYSE:MDT) position in the expanding cardiac-ablation market. The company is also investing in innovation and acquisitions, including targeted investments in intracardiac echocardiography catheter technology.
The breadth of Medtronic's (NYSE:MDT) pipeline supports the possibility that its recent acceleration can spread across more of the portfolio. Improving sentiment toward the wider medical-technology sector could provide an additional catalyst if the company maintains its execution. BTIG has argued that MedTech may be stabilizing following a period of underperformance, although company-specific results will ultimately matter more than broader sector sentiment.
#results #medtronic #healthcare
2 months ago
Former mayor of Cuauhtémoc in Mexico City, Sandra Cuevas, an influential Mexican politician, is receiving a significant amount of hate online due to sharing her recovery from cosmetic procedures.
Cuevas, 40, posted the video on X over the weekend. The video shows Cuevas dressed in a white gown with a nasal splint, tape around her eyes, and numerous bandages on her face and body. It did not specify what procedures she underwent.
"I decided to take a necessary pause. Today I choose my health, my happiness, and a new beginning full of strength," Cuevas wrote.
The video follows a couple of days of rumors surrounding the condition of the politician following her previous post dated August 19th announcing her plans to go into surgery. "I'm going into surgery! God first, if all goes well, I'll see you in about 15 hours," she wrote back then.
According to the politician, this surgery is a part of the bigger process of changing her life.
#city
Cuevas, 40, posted the video on X over the weekend. The video shows Cuevas dressed in a white gown with a nasal splint, tape around her eyes, and numerous bandages on her face and body. It did not specify what procedures she underwent.
"I decided to take a necessary pause. Today I choose my health, my happiness, and a new beginning full of strength," Cuevas wrote.
The video follows a couple of days of rumors surrounding the condition of the politician following her previous post dated August 19th announcing her plans to go into surgery. "I'm going into surgery! God first, if all goes well, I'll see you in about 15 hours," she wrote back then.
According to the politician, this surgery is a part of the bigger process of changing her life.
#city
2 months ago
Venezuela-born model and social media influencer Veronica Perasso claims that she cannot undo the illegal silicone injections she got at a friend's place because it would require open surgery and a month-long stay in another country.
Perasso, who has over 4.7 million followers on Instagram, recently began posting video tutorials about her cosmetic procedures. She emphasized that she intends to educate, not to advertise plastic surgery.
In her exclusive interview with Where Is The Buzz, the influencer elaborated on her experience. She revealed details about the night when she got injections, the advice she received from the surgeons, and explained why she feels ready to give up on her earnings for the sake of publicizing her story.
According to Perasso, she started getting plastic surgeries at the age of 20, but she chose not to conceal her breast augmentation.
"I had no problem talking about my breast augmentation, but after I did the silicone injections I felt embarrassed of what I have done to my body," she said.
#surgery #breast
Perasso, who has over 4.7 million followers on Instagram, recently began posting video tutorials about her cosmetic procedures. She emphasized that she intends to educate, not to advertise plastic surgery.
In her exclusive interview with Where Is The Buzz, the influencer elaborated on her experience. She revealed details about the night when she got injections, the advice she received from the surgeons, and explained why she feels ready to give up on her earnings for the sake of publicizing her story.
According to Perasso, she started getting plastic surgeries at the age of 20, but she chose not to conceal her breast augmentation.
"I had no problem talking about my breast augmentation, but after I did the silicone injections I felt embarrassed of what I have done to my body," she said.
#surgery #breast
